Clinical-serological correlation of lichen planus and hepatitis C virus;Correlación clínico-serológica del liquen plano y el virus de la hepatitis C

Dermatologia Revista Mexicana

Volumn 45, Issue 1, 2001, Pages 19-28

  Franco, Angélica ^a,b   Jurado, Fermín ^a  

^a CENTRO DERMATOLÓGICO DR LADISLAO DE LA PASCUA   (Mexico)

^b NONE

Author keywords

Hepatitis C virus infection; Lichen planus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LICHEN PLANUS; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SEROLOGY;

EID: 14844293268     PISSN: 01854038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Boyd A, Neldner K. Lichen planus. J Am Acad Dermatol 1991;25:593-619.
2. Larralde M, Pueyo S, Brunet A, et al. Liquen plano en la infancia. Piel 1996;9:459-61.
3. Carcassi C, Cottoni F, Floris L, et al. The HLA *0101 allele is responsible for HLA susceptibility to lichen ruber planus. Eur J Immuno 1994;21:425-9.
4. Gallegos MC, Saavedra N, Vendramini T, et al. Líquenes planos sistematizados: A propósito de 10 casos. Arch Argent Dermatol 1997;47:205-13.
5. Oral Surg Oral Med Oral Pathol 1986; 61:44-46.
6. Urbina F, Sandoval R. Pápulas hiperqueratósicas digitales. Piel 1996;11:101-04.
7. Gilhar A, Pillar T, Winterstein G. The pathogenesis of lichen planus. Br J Dermatol 1989;120:541-4.
8. Haapalainen T, Oksala O, Kallioinen M. Destruction of the epitelial anchoring system in lichen planus. J Invest Dermatol 1995;105:101-3.
9. Grande V, Magnarelli S, Berengust G, et al. Liquen ulceroso plantar. ¿Marcador de enfermedad autoinmune? Med Cut Ibero Lat Am 1998;17:307-9.
10. Nagao Y, Sata M, Itoh K, et al. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996;26:495-8.
11. Poter S, Olsen I, Barret W. Immunologic aspects of dermal and oral lichen planus. Oral Sur Oral Med Oral Pathol 1997;83:358-66.
12. Nasa G, Cottoni F, Mulargia M, et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995;132:897-900.
13. Simon M, Hunyadi J, Dobozy A, Expression of beta-2 integrin molecules on human keratinocytes in cytokine-mediated skin diseases. Acta Derm Venereol 1992:72:169-71.
14. Yamamoto T, Osaki T, Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995;104:784-9.
15. Gadenne A, Strucke R, Dunn D. T-cell lines derived form lesional skin of lichen planus patients contain a distinctive population of T-cell receptor gamma-delta-bearing cells. J Invest Dermatol 1994;103:347-51.
16. a ed. Mc. Graw Hill, 1996:306-7.
17. Abulafia J. Erupciones liquenoides: Concepto y clasificación. Arch Argent Dermat 1983;33:3-22.
18. Tamada Y, Yokochi K, Nitta Y. Lichen planus pemphigoides: Identification of 180 kd hemidesmosome antigen. J Am Acad Dermatol 1995;32:883-7.
19. Biermann H, Rauterberg W. Expression of fetal cytokeratins in epidermal cells and colloid bodies in lichen planus. J Cut Pathol 1998;25:35-43.
20. Urbina F, Ancic X, Cofré de Beca J, et al. Liquen plano lineal zosteriforme. Piel 1998;13:222-6.
21. Oleaga JM, Gardeazabal J, Sanz de Galdeano C, et al. Generalized lichen planus associated with primary biliar cirrhosis which resolved after liver transplantation. Acta Derm Venereol 1994;75:87.
22. Rebora A, Rongioletti F, Canepa A. Chronic active hepatitis and lichen planus. 1982;62:351-2.
23. Frider B, Sookoian S, Castaño G, et al. Lichen planus, chronic hepatitis C, and Interferon. Hepatology 1995;21:1764-5.
24. Tessari G, Barba A, Schena D. Lichen ruber planus following the administration of human anti-hepatitis B virus immunoglobulins. Acta Derm Venereol 1996;76:154-74.
25. Sigurgeirsson B, Lindelöf B. Lichen planus and malignancy. Arch Dermatol 1991;127:1684-8.
26. Del Cerro M, Herrera M, Rueda M, et al. Liquen plano y mieloma múltiple. Med Cut Ibero Lat Am 1996;24:259-61.
27. Tanei R, Ohta Y, Katsuoka K. Lichen planus and Sjögren-type Sicca syndrome in a patient with chronic hepatitis C. J Dermatol 1997;24:20-27.
28. Mouly F, Pawlotsky J, Schaeffer A, et al. Association of porphyria cutanea tarda and lichen planus in a patient with chronic hepatitis C virus infection. Br J Dermatol 1995;132:158.
29. Cribier B, Frances C, Chosidow O. Treatment of lichen planus. Arch Dermatol 1998;134:1521-30.
30. Simon M. Immunopathological aspects of etretinate therapy in lichen planus. J Dermatol 1990;17:282-6.
31. Kato N, Ueno H. Isolated lichen planus of the nails treated with etretinate. J Dermatol 1993;20:577-80.
32. Laurberg G, Geiger JM, Hjorth N, et al. Treatment of lichen planus with acitretin. J Am Acad Dermatol 1991;24:434-7.
33. Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial. J Am Acad Dermatol 1993;28:609-12.
34. Hildebrand A, Kolde G, Luger T, et al. Successful treatment of generalized lichen planus with recombinant interferon alfa-2b. J Am Acad Dermatol 1995;33:880-3.
35. Schlesinger T, Camisa Ch, Douglas J, et al. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection. J Am Acad Dermatol 1997;36:1023-5.
36. Wahba-Yahav A. Idiopathic lichen planus: Treatment with metronidazole. J Am Acad Dermatol 1995;33:301-2.
37. a ed. Mc Graw Hill, 1994:1676-705.
38. a ed. Ediciones Doyma, 1992:290-7.
39. a ed. Médica Panamericana, 1991:1054-77.
40. Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. Arch Dermatol 1995;131:1185-92.
41. Alvarado C, Leroux-Roels G. Inmunología de la hepatitis C. Rev Invest Clin 1999;51:315-22.
42. González-Peralta R, Davis G, Lau J. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994;21:255-9.
43. Boccia S, Gamberini S, Dalla M, et al. Lichen planus and interferon therapy for hepatitis C. Gastroenterology 1993;105:1921-2.
44. Doutre M, Beylot S, Long S. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy. Dermatology 1992;184:229.
45. Pawlotsky JM, Ben Yahia M, Andre Ch, et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 1994;19:841-8.
46. Divano M, Parodi A, Rebora A. Anti-liver-kidney microsome type 1 antibodies in lichen planus. Arch Dermatol 1992;28:991.
47. Cottoni F, Tedde G, Solinas A, et al. Lichen planus associated with anti-liver-kidney microsome-positive chronic active hepatitis and hyperthyroidism. Arch Dermatol 1991;127:1730-1.
48. Gómez E, Espinal ML, Pique E. Liquen plano y virus de la hepatitis C: Descripción de cuatro casos. Actas Dermo Sif 1993;84:451-3.
49. Miralles J, Pujol RM, Moragas J. Liquen plano y hepatitis C. Descripción de 13 casos. Actas Dermo Sif 1994;85:603-6.
50. Cainelli T, Rebora A, Tognoni G, et al. Lichen planus and liver diseases: a multicentre case-control study. Br Med J 1990;300:227-30.
51. Espinel ML, Gómez E. Liquen plano y virus de la hepatitis C. Piel 1993;8:417-9.
52. Rebora A. Hepatitis viruses and lichen planus. Arch Dermatol 1994;130:1328-9.
53. Alayon C, Giménez A, Giménez JM. Liquen plano y hepatitis C. Actas Dermosifiliogr 1995;86:9-12.
54. Mokni M, Rybojad M, Puppin D, et al. Lichen planus and hepatitis C virus. J Am Acad Dermatol 1991;24:792.
55. Agner T, Fogh H, Weismann K. The relation between lichen planus and hepatitis C: A case report. Acta Derm Venereol 1992;72:380.
56. Wiles J, Lynch P. Lichen planus and liver disease. J Am Acad Dermatol 1984;10:67.
57. Cribier B, Garnier C, Laustriat D. Lichen planus and hepatitis C virus infection: An epidemiologic study. J Am Acad Dermatol 1994;31:1070-1.
58. Bellman B, Reddy R, Falanga V, et al. Generalized lichen planus associated with hepatitis C virus immunoreactivity. J Am Acad Dermatol 1996;35:770-2.
59. Nagao Y, Sata M, Tanikawa K. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest 1995;25:910-4.
60. Tanei R, Watanabe K, Nishiyama S. Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol 1995;22:316-23.
61. Sánchez-Pérez J, De Castro M, Buezo GF, et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996;134:715-9.
62. Bagán J, Ramón C, González L, et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol 1998;85:532-6.
63. Mignogna M, Lo Muzio L, Favia G. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998;37:575-8.
64. Amichai B, Lazarov A, Halevy S. Hepatitis C virus infection and oral erosive lichen planus. J Dermatol 1994;121:783-4.
65. Dupin N, Chosidow O, Lunel F. Oral lichen planus and hepatitis C virus infection: A fortuitous association? Arch Dermatol 1997;133:1052-3.
66. Pawlotsky J M, Benchiki H, Pellet C. Lichen planus and hepatitis C virus related chronic hepatitis: evaluation of HCV genotypes. Br J Dermatol 1995;133:666-7.
67. Imhof M, Popal H, Lee JH. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Dermatology 1997;195:1-5.
68. Boyd A, Nanney B, King L. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol 1998;37:260-2.
69. Schwaber M, Zlotogorski A. Dermatologic manifestations of hepatitis C infection. Int J Dermatol 1997;36:251-4.
70. Boyd A, Nanney B, King L. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol 1998;37:260-2.
71. Schwaber M, Zlotogorski A. Dermatologic manifestations of hepatitis C infection. Int J Dermatol 1997;36:251-4.